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were followed up, it would be possible to detect a difference of 5 mmHg with a power of 90% and significance level of 5%, assuming a standard deviation of 16 mmHg. Of 3,543 hypertensive patients in the selected age range, 2,057 met the inclusion criteria and were invited to participate. Of these, 1,498 declined the invitation). A total of 441 patients were finally randomised, 227 to the intervention group and 214 to the control group.
Study design
This was a randomised controlled trial that carried out in eight general practices in the UK. The patient was the unit of randomisation. A block-stratified randomisation by practice and diabetes status was undertaken, using opaque envelopes held centrally. The duration of follow-up was one year and it was 91% complete (n=400). Though the study was not blind, the main outcome (BP) was measured in a standardised fashion using a printout from an automated manometer.
Analysis of effectiveness
The primary outcome was change in systolic BP between baseline and follow-up (at 6 and 12 months). The analysis was conducted on an intention to treat basis using the complete case method. A sensitivity analysis explored assumptions for missing values. The groups were broadly comparable at baseline except for gender (52% versus 43% male in the intervention versus control group), which was included in the analytical model as pre-specified in the analysis plan to account for possible confounding. The secondary outcomes were: changes in diastolic BP; anxiety, as measured using the short form of the Spielberger state anxiety inventory; the body mass index, (using electronic scales); and the patients' preferences for BP measurement (i.e. doctor, nurse, self-measurement at the surgery, or self-measurement at home).
Effectiveness results
Systolic BP in the intervention group was significantly reduced after 6 months in comparison with the control group, but not after 1 year. The adjusted mean difference in change was 4.3 mmHg (95% confidence interval, CI: 0.8 -7.9; p=0.004) at 6 months and 2.7 mmHg (95% CI: -1.2 -6.6) after 1 year.
No difference was found in diastolic BP, anxiety or health behaviours.
The body mass index reduced significantly more over time in the intervention group than in the control group, (p=0.005).
Reported alcohol intake reduced significantly in the intervention group when compared with the control group in the first 6 months, (p=0.03), but not thereafter, (p=0.56).
The patients in the intervention group ranked home measurement highest, followed by self-measurement in the surgery. Those in the control group ranked measurement by a doctor highest, followed by measurement by a nurse. The difference in ranking was statistically significant, (p<0.001).
Adjustment variables included practice (nested within intervention), diabetes status and gender.
Clinical conclusions
Practice-based self-monitoring resulted in small but significant improvements of BP at 6 months, which were not sustained after 1 year.
